Goat anti-Human IgG Fc Secondary Antibody [DyLight 594]
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-74995DL594
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Chemiluminescence Immunoassay, ELISA, Flow Cytometry, Immunoassay, Immunocytochemistry/ Immunofluorescence, Immunohistochemistry, Immunomicroscopy, Western Blot
Label
DyLight 594 (Excitation = 593 nm, Emission = 618 nm)
Antibody Source
Polyclonal Goat IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Purified Human IgG, Fc fragment
Specificity
Based on Immunoelectrophoresis, this antibody reacts with heavy (gamma) chains on human IgG. IgG serum proteins.
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Applications for Goat anti-Human IgG Fc Secondary Antibody [DyLight 594]
Application
Recommended Usage
ELISA
1:100-1:2000
Flow Cytometry
1:10-1:1000
Immunocytochemistry/ Immunofluorescence
1:10 - 1:500
Immunohistochemistry
1:10 - 1:500
Immunomicroscopy
1:10 - 1:500
Western Blot
1:100-1:2000
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: IgG Fc
UniProt
Additional IgG Fc Products
Product Documents for Goat anti-Human IgG Fc Secondary Antibody [DyLight 594]
Product Specific Notices for Goat anti-Human IgG Fc Secondary Antibody [DyLight 594]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Secondary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...